pulmonary neoplasm
Conditions
Interventions
1:Superficial serratus anterior group: under the guidance of ultrasound, the fifth intercostal needle was inserted in the midaxillary line on the affected side, and 20ml ropivacaine (0.375%) was injec
2:Deep serratus anterior group: under the guidance of ultrasound, the fifth intercostal needle was inserted in the midaxillary line of the affected side, and 20ml of 0.375% ropivacaine was injected i
3:In the complex group of superficial and deep serratus anterior muscle, 10ml ropivacaine 0.375% was injected into the deep surface of serratus anterior muscle and 10ml ropivacaine 0.375% was injected
Sponsors
The First People's Hospital of Kunshan City
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-70 years; 2. Selective thoracoscopic lobectomy 3. ASA class I-II.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindication of nerve block, such as infection of puncture site, spinal deformity, trauma or operation history; 2. With dysfunction of heart, lung, liver or kidney; 3. Allergic to local anesthetics or opioids; 4. Patients with severe motion sickness; 5. Dyslexic.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PHPS Score;The ratio of effective pressing times (D1) to actual pressing times (D2) of PCEA pump within 24h (D1;QoR-40 Score;Adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ramsay Score; | — |
Countries
China
Contacts
Public ContactBingqiang Ma
Department of Anesthesiology, the First People's Hospital of Kunshan City
Outcome results
None listed